Jf. Riou et al., ALTERED TOPOISOMERASE-I ACTIVITY AND RECOMBINATION ACTIVATING GENE-EXPRESSION IN A HUMAN LEUKEMIA-CELL LINE RESISTANT TO DOXORUBICIN, Biochemical pharmacology, 46(5), 1993, pp. 851-861
We examined the expression of the genes encoding topoisomerases I and
II and those associated with V(D)J [variable(diversity)joining] recomb
ination in two human T-cell acute lymphoblastic leukemia (T.ALL) cell
lines, CEM and CEM/DOX. In CEM/DOX cells, which are resistant to doxor
ubicin, the topoisomerase I gene was found to be 4-fold overexpressed
and nuclear topoisomerase I relaxation activity was 2-fold greater in
CEM/DOX than in CEM cells. Furthermore, the cleavable complex reaction
induced by camptothecin, a specific topoisomerase I inhibitor, was fo
und to be 2.5-increased in the presence of topoisomerase I extracted f
rom CEM/DOX, in comparison to that in CEM cells. Conversely, the topoi
somerase II mRNA levels, nuclear decatenation activities and (mAMSA) 9
-acridinylamino)methanesulfon-m-anisidide-induced cleavable complex fo
rmation in CEM/DOX were similar to those of the doxorubicin-sensitive
cells. The results indicate that topoisomerase I activity is elevated
in CEM/DOX cells. Nevertheless, CEM/DOX cells were 11-fold more resist
ant to camptothecin than were CEM cells, and cross-resistance to campt
othecin was not reversed by verapamil. Furthermore, using an intact ce
ll assay for DNA-protein complexes, we found that camptothecin-stimula
ted cleavable complexes formed in CEM/DOX cells were increased in corr
elation with the elevated topoisomerase I activity. These results sugg
est that camptothecin resistance in CEM/DOX cells is due to different
mechanism(s) than topoisomerase- or P-glycoprotein-associated multidru
g resistance. The recombination activating gene, RAG1, which is one of
the components of the site-specific V(D)J recombination complex, was
20-fold overexpressed in CEM/DOX cells. In contrast, RAG2 and T160 gen
e transcripts, other components of the V(D)J complex, were at best poo
rly detected in both sensitive and resistant cells. No specific V(D)J
recombinase activity was found in CEM or CEM/DOX cells when the pJH201
transfection assay was used. The results indicate that CEM/DOX cells
failed to generate V(D)J recombination although RAG1 gene is overexpre
ssed. The mechanism of the RAG1 gene activation was not gene amplifica
tion, and no rearrangement was detected in the RAG1 gene locus. RAG1 p
resents homology with the yeast gene HPR1, itself homologous to yeast
topoisomerase I and responsible for the control of recombination in so
matic cells. Since DNA topoisomerases are themselves involved in the c
ontrol of DNA topology, recombination and DNA repair, the possible coa
ctivation of RAG1 and topoisomerase I genes in CEM/DOX cells is discus
sed.